PHASE I (EARLY PHASE) We understand that that a molecule, at the start of its journey, requires the most attention to make it into a potential life saver drug in the future. With our expertise in handling various types of studies, experience in a wide range of therapeutic area, our ability to handle different dosage forms and complicated protocols enables us to provide innovative and quality solutions to your studies. Our services for phase I trials includes designing and managing of First in man studies, Proof of concept studies, Bioavailability and Bioequivalent studies, Drug interaction studies, Dose escalation studies, safety studies and special population studies. We will be assigning a dedicated team headed by a project manager, all of whom will be experienced in handling your requirements along with the therapeutic knowledge required. The team will be accessible to you anywhere, anytime which will allow establishing good communication, robust planning and minimising risks in the most time and cost efficient manner. After all, patient safety is achieved through protocol compliance and our working model will ensure that this is achieved with highest quality standards including GLP, ICH, GCP and all other local regulatory guidelines. ASSAY with its technologies and expertise will assist you through every step of your trial. PHASE II/III Due to the sheer size and complexity of phase II and III trials in terms of recruitment, duration of the study and the costs involved, it is important that the most experienced and trained resources are available in order to obtain the most accurate results. At ASSAY, we have the ability to get connected to the perfect resources and expertise throughout the globe which will ensure that clients / sponsors are provided customized plans to execute their clinical trials successfully within the timelines and budget and with high quality standards. We offer Clinical monitoring, Data Management, Project Management, Investigator Recruitment and site management, Protocol and CRF designing, Patient Reported Outcome management, Feasibility studies, Interactive technologies and any other customized services as required by the clients or project. ASSAY is committed to patient safety, ethics, quality and paramount client service. PHASE IV (LATE PHASE) A safe journey from development to commercialization is vital to make the drug reach out to the humanity. ASSAY with its trusted partners will successfully conduct post marketing studies through our strong therapeutic expertise, good documentation and effective communication. ASSAY will strive to assist our sponsors in the post-approval process in a cost effective manner within the expected timelines. REGULATORY Clinical Trial set-up is the first and most crucial step towards successfully conducting the trial for the given duration.